Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs (NYSE:PFE)
Pfizer shares lagged behind pharma rally due to inflated expectations, one-time losses, write-offs, and the Seagen acquisition. Find out why PFE stock is a Buy.
Source: seekingalpha.com